Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay
Summary: Peptide mobility shift assays provide a sensitive measure of kinase enzymatic activity and can be used to evaluate kinase inhibitors. Herein, we describe a protocol adapted for rapid assessment of doublecortin-like kinase inhibitors. Advantages include rapid iterations of therapeutic compou...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | STAR Protocols |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266616672100294X |
_version_ | 1829502314314989568 |
---|---|
author | Yan Liu Kenneth D. Westover |
author_facet | Yan Liu Kenneth D. Westover |
author_sort | Yan Liu |
collection | DOAJ |
description | Summary: Peptide mobility shift assays provide a sensitive measure of kinase enzymatic activity and can be used to evaluate kinase inhibitors. Herein, we describe a protocol adapted for rapid assessment of doublecortin-like kinase inhibitors. Advantages include rapid iterations of therapeutic compound assessment and the ability to characterize kinase mutations, such as drug-resistant mutants for biological rescue experiments, on kinase activity.For complete details on the use and execution of this protocol, please refer to Liu et al. (2020). |
first_indexed | 2024-12-16T09:36:00Z |
format | Article |
id | doaj.art-9cb2921000cf45d5adecab4106b3f7fa |
institution | Directory Open Access Journal |
issn | 2666-1667 |
language | English |
last_indexed | 2024-12-16T09:36:00Z |
publishDate | 2021-06-01 |
publisher | Elsevier |
record_format | Article |
series | STAR Protocols |
spelling | doaj.art-9cb2921000cf45d5adecab4106b3f7fa2022-12-21T22:36:25ZengElsevierSTAR Protocols2666-16672021-06-0122100587Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assayYan Liu0Kenneth D. Westover1Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA; Department of Radiation Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA; Corresponding authorDepartment of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA; Department of Radiation Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA; Corresponding authorSummary: Peptide mobility shift assays provide a sensitive measure of kinase enzymatic activity and can be used to evaluate kinase inhibitors. Herein, we describe a protocol adapted for rapid assessment of doublecortin-like kinase inhibitors. Advantages include rapid iterations of therapeutic compound assessment and the ability to characterize kinase mutations, such as drug-resistant mutants for biological rescue experiments, on kinase activity.For complete details on the use and execution of this protocol, please refer to Liu et al. (2020).http://www.sciencedirect.com/science/article/pii/S266616672100294Xcancerhigh-throughput screeningmolecular/chemical probesprotein biochemistry |
spellingShingle | Yan Liu Kenneth D. Westover Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay STAR Protocols cancer high-throughput screening molecular/chemical probes protein biochemistry |
title | Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay |
title_full | Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay |
title_fullStr | Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay |
title_full_unstemmed | Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay |
title_short | Rapid assessment of DCLK1 inhibitors using a peptide substrate mobility shift assay |
title_sort | rapid assessment of dclk1 inhibitors using a peptide substrate mobility shift assay |
topic | cancer high-throughput screening molecular/chemical probes protein biochemistry |
url | http://www.sciencedirect.com/science/article/pii/S266616672100294X |
work_keys_str_mv | AT yanliu rapidassessmentofdclk1inhibitorsusingapeptidesubstratemobilityshiftassay AT kennethdwestover rapidassessmentofdclk1inhibitorsusingapeptidesubstratemobilityshiftassay |